Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYM
1676
DELISTED
Plymouth Industrial REIT
PLYM
| $3.82M | 0.01% |
199,212
+900
| +0.5% | +$17K |
|
1677
Popular Inc
BPOP
$11.2B
| $3.81M | 0.01% |
57,525
-80,400
| -58% | -$5.59M |
|
|
FIRY
1678
Firy Inc
FIRY
$146M
| $3.81M | 0.01% |
376,431
+79,351
| +27% | +$1.46M |
|
|
VOXX
1679
DELISTED
VOXX International Corporation Class A
VOXX
| $3.81M | 0.01% |
455,022
-141,300
| -24% | -$1.28M |
|
1680
Radian Group
RDN
$5.27B
| $3.8M | 0.01% |
199,500
+67,900
| +52% | +$1.32M |
|
|
DICE
1681
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $3.79M | 0.01% |
+121,300
| New | +$3.96M |
|
|
TPC
1682
Tutor Perini Cor
TPC
$4.51B
| $3.77M | 0.01% |
499,080
-9,300
| -2% | -$65.9K |
|
|
DEA
1683
Easterly Government Properties
DEA
$1.18B
| $3.77M | 0.01% |
105,560
+19,160
| +22% | +$745K |
|
|
FLG
1684
Flagstar Bank National Association
FLG
$5.95B
| $3.77M | 0.01% |
145,947
-509,261
| -78% | -$13.6M |
|
1685
Atlanticus Holdings
ATLC
$1.67B
| $3.76M | 0.01% |
143,658
-16,700
| -10% | -$446K |
|
|
PRPH
1686
DELISTED
ProPhase Labs
PRPH
| $3.75M | 0.01% |
38,941
+1,260
| +3% | +$136K |
|
1687
Bank of Hawaii
BOH
$3.19B
| $3.75M | 0.01% |
48,300
+17,700
| +58% | +$1.37M |
|
|
BPMC
1688
DELISTED
Blueprint Medicines
BPMC
| $3.74M | 0.01% |
+85,400
| New | +$4.1M |
|
1689
Crawford & Co Class B
CRD.B
$555M
| $3.72M | 0.01% |
701,410
-25,100
| -3% | -$140K |
|
1690
LyondellBasell Industries
LYB
$19.7B
| $3.72M | 0.01% |
44,800
-238,200
| -84% | -$19.5M |
|
1691
Comfort Systems
FIX
$62.5B
| $3.72M | 0.01% |
+32,300
| New | +$3.76M |
|
|
AKRO
1692
DELISTED
Akero Therapeutics
AKRO
| $3.7M | 0.01% |
67,600
+3,500
| +5% | +$150K |
|
|
ETRN
1693
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.7M | 0.01% |
552,499
+537,699
| +3,633% | +$4.17M |
|
|
RNAM
1694
DELISTED
Avidity Biosciences
RNAM
| $3.7M | 0.01% |
166,600
+42,600
| +34% | +$635K |
|
1695
Friedman Industries
FRD
$255M
| $3.69M | 0.01% |
377,462
-16,320
| -4% | -$147K |
|
1696
Schrodinger
SDGR
$1.17B
| $3.69M | 0.01% |
197,600
-32,300
| -14% | -$670K |
|
|
API
1697
Agora
API
$346M
| $3.66M | 0.01% |
936,666
-242,683
| -21% | -$801K |
|
1698
Archrock
AROC
$6.26B
| $3.66M | 0.01% |
407,100
-205,228
| -34% | -$1.64M |
|
|
PFSW
1699
DELISTED
PFSweb, Inc.
PFSW
| $3.65M | 0.01% |
593,454
-13,356
| -2% | -$125K |
|
1700
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.18B
| $3.64M | 0.01% |
246,200
-131,800
| -35% | -$2.2M |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.